Breast cancer vaccine - Oregon Health Sciences University

Drug Profile

Breast cancer vaccine - Oregon Health Sciences University

Latest Information Update: 06 Sep 2002

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class Cancer vaccines
  • Mechanism of Action Immunomodulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Breast cancer

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 10 Aug 1999 A study has been added to the Cancer immunogenicity and adverse events sections
  • 08 Mar 1999 Phase-I clinical trials for Breast cancer in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top